what are glp 1 drugs made from GLP-1 Receptor Agonist Services for Type 2 Diabetes and Obesity Drug Development Compounded" GLP-1 drugs | Health

(2014) 6:237ra65

this difference may result from a ~5x stronger effect produced by GLP-1 analogs, compared to DPP-4 inhibitors (Charbonnel & Cariou, 2011) No change in weight Contraindications: type I diabetes (these patients lack pancreatic beta cells) diabetic ketoacidosis (it would not be effective for treating this condition) an association between DPP-4 inhibitors and heart failure has been observed for two members of this drug class in patients with type 2 DM and atherosclerosis

, , L- , :

Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome